Cargando…
TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling
Epithelial ovarian cancer (EOC) is the most deadly gynaecologic malignancy due to late onset of symptoms and propensity towards drug resistance. Epithelial-mesenchymal transition (EMT) has been linked to the development of chemoresistance in other cancers, yet little is known regarding its role in E...
Autores principales: | Roberts, Cai M., Tran, Michelle A., Pitruzzello, Mary C., Wen, Wei, Loeza, Joana, Dellinger, Thanh H., Mor, Gil, Glackin, Carlotta A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120297/ https://www.ncbi.nlm.nih.gov/pubmed/27876874 http://dx.doi.org/10.1038/srep37652 |
Ejemplares similares
-
Disruption of TWIST1-RELA binding by mutation and competitive inhibition to validate the TWIST1 WR domain as a therapeutic target
por: Roberts, Cai M., et al.
Publicado: (2017) -
RNA-Based TWIST1 Inhibition via Dendrimer Complex to Reduce Breast Cancer Cell Metastasis
por: Finlay, James, et al.
Publicado: (2015) -
TWIST1, A novel androgen-regulated gene, is a target for NKX3-1 in prostate cancer cells
por: Eide, Turid, et al.
Publicado: (2013) -
CBX7 binds the E-box to inhibit TWIST-1 function and inhibit tumorigenicity and metastatic potential
por: Li, Juanni, et al.
Publicado: (2020) -
Harmine inhibits breast cancer cell migration and invasion by inducing the degradation of Twist1
por: Nafie, Ebtesam, et al.
Publicado: (2021)